Current Advances and Future of Premium IOLs

The objective of this review is to outline the current state of premium IOLs on the market and present outcome data to assess their benefits and limitations. This review will also explore premium IOLs in development.Recent FindingsExtended depth of focus (EDOF) IOLs improve functional vision over a range of distances and correct for presbyopia by creating a single, elongated focus. The IC-8 (AcuFocus) uses a small aperture and provides a promising option for patients with irregular refractive states. The AcrySof Vivity (Alcon) uses a shifting wavefront to allow extended depth of focus while reducing dysphotopsias, and the Tecnis Eyhance (J&J) uses a progressive power change to improve intermediate distance visual acuity. Multifocal IOLs such as the PanOptix (Alcon) provide effective intermediate and near visual acuity but the use of diffraction results in increased photic effects. The Tecnis Synergy (J&J) combines multifocal and EDOF technology to provide a wider range of functional focus. The development of light-adjustable lens such as RxSight makes it possible to adjust lens power postoperatively using ultraviolet irradiation. Modular IOLs are a new generation of IOLs in the pipeline that have a multiple component design to enable easier optic exchange. The Juvene (LensGen) has received investigational device exemption approval from the FDA and other modular IOLs such as Harmoni and Gemini are also in development.SummaryInnovations in IOLs are providing increased o...
Source: Current Surgery Reports - Category: Surgery Source Type: research